Challenges in analyzing real-world evidence: analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study.
- DOI
- 10.1016/j.esmorw.2025.100149
- Published
- 2025 Jun
- Container
- ESMO real world data and digital oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmorw.2025.100149,
title = {Challenges in analyzing real-world evidence: analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study.},
author = {Tran B and Yeh N and Gayle A and Holmes E and Hu J and Damineni S and Kebede N and Shore N},
year = {2025},
journal = {ESMO real world data and digital oncology},
doi = {10.1016/j.esmorw.2025.100149},
url = {https://doi.org/10.1016/j.esmorw.2025.100149}
}RIS
TY - JOUR TI - Challenges in analyzing real-world evidence: analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study. AU - Tran B AU - Yeh N AU - Gayle A AU - Holmes E AU - Hu J AU - Damineni S AU - Kebede N AU - Shore N PY - 2025 JO - ESMO real world data and digital oncology DO - 10.1016/j.esmorw.2025.100149 UR - https://doi.org/10.1016/j.esmorw.2025.100149 ER -
APA
B, T., N, Y., A, G., E, H., J, H., S, D., N, K., & N, S. (2025). Challenges in analyzing real-world evidence: analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study.. ESMO real world data and digital oncology. https://doi.org/10.1016/j.esmorw.2025.100149
Source records
- pubmed · retrieved 2026-09-26T17:11:15.151Z